<DOC>
	<DOCNO>NCT00945698</DOCNO>
	<brief_summary>The use lipid-based nutrient ( LNS ) , Nutributter fortify spread ( FS ) , associate improved growth development outcomes among infant Ghana Malawi . Modified version supplement develop improve nutrient density quality low cost . Such modified product proven acceptable infant guardian Malawi Ghana . In present trial , investigator aim identify low growth-promoting daily dose modify LNS . Additionally , investigator test hypothesis LNS contain milk promote growth well milk-containing LNS give 12 month 10-40 g daily dose 6-18 month old infant rural Malawi .</brief_summary>
	<brief_title>Prevention Linear Growth Failure Infants Young Children With Lipid-based Nutrient Supplements ( iLiNS-DOSE )</brief_title>
	<detailed_description>Six-month old healthy infant identify community survey study area . 1920 infant meet set criterion randomise receive follow intervention 6 18 month age : 1 ) standard treatment 6-18 month ( i.e.no supplement , delay intervention 18-30 month age ( ST-DI ) , 2 ) 10 g / day milk-containing LNS ( LNS-10gM ) , 3 ) 20 g / day milk-containing LNS ( LNS-20gM ) , 4 ) 20 g / day milk-free LNS ( LNS-20gNoM ) , 5 ) 40 g / day milk-containing LNS , ( LNS-40gM ) 6 ) 40 g / day milk-free LNS ( LNS-40gNoM ) . The family receive food supplement 2-weekly interval participant undergo morbidity evaluation weekly , limit development assessment 4-weekly interval anthropometric evaluation 26-week interval laboratory analyse enrollment 18 month . Growth outcome analyse do 18 42 month age .</detailed_description>
	<mesh_term>Malnutrition</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin A</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Retinol palmitate</mesh_term>
	<criteria>Signed informed consent least one guardian Age 5.50 month 6.49 month Availability period study . Permanent resident Mangochi District Hospital Namwera Health Centre catchment area Weight length Z score ( WLZ ) &lt; 2.0 Presence oedema Severe anaemia ( Hb &lt; 50 g / l ) Severe illness warrant hospital referral History allergy towards peanut History anaphylaxis serious allergic reaction substance , require emergency medical care Concurrent participation clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>167 Days</minimum_age>
	<maximum_age>197 Days</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Stunting</keyword>
	<keyword>Growth failure</keyword>
	<keyword>Malnutrition</keyword>
	<keyword>Lipid base nutrient supplement</keyword>
	<keyword>LNS</keyword>
	<keyword>Prevention</keyword>
	<keyword>Malawi</keyword>
	<keyword>Sub-Saharan Africa</keyword>
	<keyword>Dietary supplementation</keyword>
	<keyword>Efficacy</keyword>
</DOC>